BEIJING TIANTAN BIOLOGICAL PRODUCTS CO., LTD.

Autres langues Beijing Tiantan Biological Products Co., Ltd.

Actions

600161

CNE000000WF9

Cours en clôture Shanghai S.E. Autres places de cotation 00:00:00 15/07/2024			Varia. 5j.	Varia. 1 janv.
23,95 ^CNY	+2,35%		+0,93%	-7,11%

27/06	China Construction Bank Corporation annonce des nominations au conseil d'administration	CI
16/05	Le vice-président exécutif de Bank of China démissionne	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

China Construction Bank Corporation Announces Board and Committee Changes	27/06
Bank of China Executive Vice President Steps Down	16/05
ICBC, CCB Name Deputy Party Secretaries	02/05
Tiantan Biological Products' Q1 Profit Jumps 21%; Shares Rise 7%	12/04
Beijing Tiantan Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	11/04
Tiantan Biological Products Scraps Clinical Trial of Intravenous Cytomegalovirus Human Immunoglobulin	01/02
Beijing Tiantan Biological Products Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	10/01
China Baoli Technologies Chairman Redesignated as Vice Chairman	30/11
Didi Global Reports Q3 Revenue of RMB 51.4 Billion, Up 25% YoY	13/11
DIDI- ON NOV 11, YI ZHANG RESIGNED AS DIRECTOR OF THE CO, CHEN S…	13/11
Tiantan Biological Products Secures Another Blood Collection License	02/11
Beijing Tiantan Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25/10/23
Tiantan Biological Products' Profit Jumps 47.7% in First Three Quarters; Shares Up 5%	13/10/23
Tiantan Biological Products' Unit Gets Nod to Register Intravenous Human Immunoglobulin, Passes Regulatory Inspection	27/09/23
Beijing Tiantan Biological Products Co., Ltd.(XSSC:600161) added to S&P Global BMI Index	18/09/23
Beijing Tiantan Biological Products Co., Ltd.(XSSC:600161) added to FTSE All-World Index	18/09/23
Beijing Tiantan Biological Products Lands Blood Collection License in China’s Liping County	15/09/23
Tiantan Biological Unit Registers Blood Disorder Treatment; Shares Jump 4%	11/09/23
Tiantan Biological Products Secures Another Blood Plasma Collection License	07/09/23
Beijing Tiantan Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	13/07/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Beijing Tiantan Biological Products Co., Ltd.

Actions

600161

CNE000000WF9

Autres langues

Filtres